Quoin Pharmaceuticals Q1 EPS $(1.11) Compared With $(4.09) YoY, Quoin Had Approximately $14.7M In Cash & Equivalents As Of March 31, 2024
Quoin Pharmaceuticals Q1 EPS $(1.11) Compared With $(4.09) YoY, Quoin Had Approximately $14.7M In Cash & Equivalents As Of March 31, 2024
截至2024年3月31日，Quoin Pharmicals第一季度每股收益爲1.11美元（1.11美元），與同比增長4.09美元（4.09美元）相比，Quoin的現金及等價物約爲1470萬美元
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.76) by 46.05 percent. This is a 72.79 percent increase over losses of $(4.08) per share from the same period last year.
Quoin Pharmicals（納斯達克股票代碼：QNRX）公佈的季度虧損爲每股1.11美元，比分析師普遍預期的0.76美元（0.76美元）低46.05％。與去年同期每股虧損4.08美元（4.08）相比，增長了72.79％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。